Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2003
08/14/2003US20030153751 Inhibitors of phospholipase enzymes
08/14/2003US20030153613 Hypotensive agents for eye, using an aclurea indole compounds, potassium channel blockers; glaucoma
08/14/2003US20030153611 Antitumor agents promoting the detachment of endothelial cells forming tumor, inhibiting tubulin polymerization
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists
08/14/2003US20030153576 Such as amino-indazoles for treatment of central nervous system disorders
08/14/2003US20030153560 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003DE19933313C2 Mittel und Verfahren zur Färbung von Haaren Compositions and methods for dyeing hair
08/14/2003CA2474532A1 Sulfonate derivatives and the use therof as latent acids
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/13/2003EP1334719A2 Pentafluorobenzenesulfonamides and analogs
08/13/2003EP1334083A2 1,4-disubstituted benzenes as insecticides
08/13/2003EP1333832A1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
08/13/2003EP1333824A2 Treatment of sexual dysfunction
08/13/2003EP1178987B1 Substituted benzoylisoxazoles and the use thereof as herbicides
08/13/2003EP0946539B1 Sulphonamide derivatives, process for their preparation, and their use as medicaments
08/13/2003EP0891328B1 Peptidyl compounds having mmp and tnf inhibitory activity
08/13/2003CN1117731C Benzo-pentaheterocyclic ring sulfonyl urea compound, its preparation method and herbicide using said compound as active component
08/12/2003US6605721 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605615 Administering to a patient suffering from hypercholesterolemia, hyperlipedimea and other metabolic disorders an effective amount of hydrozone, oxime or imine derivatives
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/07/2003WO2003064433A1 Polymerization catalyst activator and its use in a polymerization process
08/07/2003WO2003064392A1 Process for the manufacture of hmg-coa reductase inhibitors
08/07/2003WO2003064388A2 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003064384A2 Environment friendly reagents and process for trifluoromethylsulfinylation of organic compounds
08/07/2003WO2003064373A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003010361A3 Nitrogen atom transfer
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/07/2003US20030149050 Inhibitors of inflammation and reperfusion injury and methods of use thereof
08/07/2003US20030149048 For therapy of hyperproliferative disorder in a mammal
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/07/2003US20030148877 Metallocenes and catalysts for olefin-polymerisation
08/07/2003CA2474595A1 Polymerization catalyst system and its use in a polymerization process
08/07/2003CA2473803A1 Substituted indoles as alpha-1 agonists
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1333026A1 Process for the preparation of high purity perindopril and intermediates useful in the synthesis
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332127A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
08/06/2003EP1331935A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
08/06/2003CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/05/2003US6603006 Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use
08/05/2003US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
08/05/2003CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/05/2003CA2077708C Cyclic nitrones
07/2003
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062200A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
07/31/2003WO2003062186A1 Metal salts of (3s)-3-methoxycarbonyl-4-phenylbutyric acid and usage thereof
07/31/2003WO2003061660A1 Melanocortin receptor agonists
07/31/2003WO2003020677A3 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
07/31/2003WO2002062762A3 Potassium channel openers
07/31/2003WO2002020500A3 Materials and methods to potentiate cancer treatment
07/31/2003US20030144526 Calcium receptor-active compounds
07/31/2003US20030144520 Inhibit p38- alpha kinase using compounds of the formula and the pharmaceutically acceptable salts thereof, or a pharmaceutical composition thereof, wherein noninterfering substituent;
07/31/2003US20030144504 Dialkyl-halogenophenyl-substituted ketoenols
07/31/2003US20030144339 Treatment of inflammatory disease, arthritis, asthma
07/31/2003US20030144338 Pyrrole derivative
07/31/2003US20030144323 Phenylalkynes
07/31/2003US20030144282 Inhibitors of cytosolic phospholipase A2
07/31/2003US20030144278 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
07/31/2003US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same
07/31/2003US20030144275 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis
07/31/2003US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics
07/31/2003US20030144267 Novel compounds
07/31/2003US20030144265 HIV protease inhibitors based on amino acid derivatives
07/31/2003US20030143699 Process for the preparation of optically active azabicyclo heptanone derivatives
07/31/2003US20030143422 [5]-helicene and dibenzofluorene materials for use in organic light emitting devices
07/31/2003US20030140820 Pigmented vitreous material
07/31/2003CA2473036A1 Melanocortin receptor agonists
07/30/2003EP1331222A1 Environment friendly reagents and process for halogenoalkylsulfinylation of organic compounds
07/30/2003EP1331005A1 Medicinal compositions for concominant use as anticancer atent
07/30/2003EP1330457A2 Cyclopenta[b][1,4] diazepino[6,7,1-hi]indoles as 5ht2c antagonists
07/30/2003EP1330435A1 Crystalline forms of fluvastatin sodium
07/30/2003EP1330430A2 Integrin receptor inhibitors
07/30/2003EP1330426A1 Selective maxi-k- potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
07/30/2003EP1330233A1 Method of treating stroke
07/30/2003EP1189885B1 Process for the synthesis of a-nor-seco compounds with sterane skeleton
07/30/2003EP0592439B1 Aminosulfonyl carbamates
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433403A Solid pharmaceutical preparation
07/29/2003US6600074 Perfluoroalkylated aniline compound and process for producing the same
07/29/2003US6600039 Using potassium-t-butylate in tetrahydrofuran. it is not easy to carry out the process under industrial conditions, yield is low, the product is contaminated, its purification requires repeated crystallization. that by stirring in dimethyl
07/29/2003US6599938 Optionally substituted Schiff base condensation products comprising an amino acid component and a benzaldehyde component, that have MIF (macrophage migration inhibitory factor) antagonist activity
07/29/2003US6599929 1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor
07/29/2003US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments
07/29/2003CA2056065C Preparation of 3-alkylated indoles
07/25/2003CA2369271A1 Light-induced modification of indole and trytophan
07/24/2003WO2003059900A1 Coumarin derivatives, process for their production and use thereof